Focusing on IFNα secreted by infected cancer cells, it was shown in the RG2 rat glioma cell line treated with the myxoma oncolytic virus that the adjunction of the mTOR inhibitor rapamycin decreased the expression of IFNα in vitro. Here, IFNA1 is linked to central nervous system cancer.